Targeting the BCL-2 protein family provides a promising area of investigation for the treatment of paediatric nervous system tumours [27], as the anti-apoptotic BCL-2 family members BCL-2, BCL-XL, and MCL-1 are frequently upregulated in cancer cells, including MB and NB [26]. Here, MCL1 is linked to cancer.